Andson Biotech

Atlanta, GA · Founded 2020 · Privately Held (backing)

Developer of a novel Process Analytical Technology (PAT) designed for cell-based bioprocesses. Andson Biotech is based in Atlanta, GA and was founded in 2020. It was valued at $17.5 million at its seed round in Oct 2025, the last priced event on record. It has raised $9 million across 2 recorded rounds; the latest was a $4.7 million seed round in Oct 2025.

PMV mark · valuation
$17.5M
Oct 2026
Priced at
its seed round
Oct 2025
Total raised
$9.0M
Last round
Seed Round
Oct 2025
What is Andson Biotech worth?
$17.5MPrivateMarketView mark · Oct 2026

Valued at $17.5M at its seed round, Oct 2025. Nothing has traded since.

Free account
More of Andson Biotech with a free account
  • ·Watch Andson Biotech: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Andson Biotech funding history

2 rounds
DateRoundRaisedPost-money
Oct 2025Seed Round$4.7M▮
Mar 2024Seed Round$3.6M▮
Unlock post-money valuations

Membership and data by Private Market View

Andson Biotech valuation

Andson Biotech was valued at $17.5 million at its seed round in Oct 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Andson Biotech raised?

Andson Biotech has raised $9 million across 2 recorded rounds since 2024. The largest was a $4.7 million seed round in Oct 2025.

Andson Biotech has filed 1 Form D with the SEC, most recently in Mar 2024 ($3.6 million sold to 37 investors).

How Andson Biotech's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Andson Biotech, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Andson Biotech

What is Andson Biotech worth?
Andson Biotech is valued at $17.5M as of Oct 2026. Valued at $17.5M at its seed round, Oct 2025. Nothing has traded since.
How much has Andson Biotech raised?
Andson Biotech has raised $9.0M in total funding across 2 recorded rounds.
When did Andson Biotech last raise?
Andson Biotech last raised in Oct 2025 (Seed Round), raising $4.7M.